Ascendis Pharma Announces Second Quarter Financial Results
![Ascendis Pharma Announces Second Quarter Financial Results](https://investorshangout.com/images/blog/ihnews-Ascendis%20Pharma%20Announces%20Second%20Quarter%20Financial%20Results.jpg)
Ascendis Pharma to Report Second Quarter 2024 Financial Results
Ascendis Pharma A/S (NASDAQ: ASND) has announced its schedule to report financial results for the second quarter of 2024. The announcement indicates that the financial report will be released after the U.S. financial markets close on a designated date. This follows the company's practice of communicating significant updates to its investors and stakeholders promptly.
Details of the Upcoming Announcement
On the same day, the company intends to host a conference call combined with a live webcast to discuss the financial results and provide a comprehensive business update. The scheduled time for this event is set at 4:30 p.m. Eastern Time, allowing interested parties to engage in the discussion regarding the company’s performance and future outlook.
Accessing the Conference Call
For those who are keen to gain insights into Ascendis Pharma's quarterly performance, accessing the live webcast is highly encouraged. Participants can join the conference call through dedicated access links provided by the company. Following the event, a replay of the webcast will be available for 30 days, enabling stakeholders to review the discussion at their convenience.
About Ascendis Pharma A/S
Ascendis Pharma is dedicated to advancing innovative therapeutic solutions through its proprietary TransCon technology platform. The company aims to establish itself as a leading integrated biopharmaceutical entity by focusing on enhancing the wellbeing of patients worldwide. Through its commitment to applying cutting-edge science, Ascendis Pharma develops new therapies that have the potential to substantially improve patient outcomes.
Company Philosophy and Values
At the heart of Ascendis Pharma's mission are the core values that guide its operations: Patients, Science, and Passion. These values embody the company's dedication to delivering top-tier medical advancements while prioritizing patient needs and scientific rigor. Ascendis Pharma operates from its headquarters in Copenhagen, Denmark, with additional facilities in Europe and the United States, facilitating a broad spectrum of research and development activities.
Contact Information
For any inquiries regarding investor relations or media-related questions, Ascendis Pharma has provided dedicated contact personnel:
Investor Contacts:
Tim Lee
Ascendis Pharma
Phone: +1 (650) 374-6343
Email: tle@ascendispharma.com
Email: ir@ascendispharma.com
Media Contact:
Melinda Baker
Ascendis Pharma
Phone: +1 (650) 709-8875
Investor Relations:
Patti Bank
ICR Westwicke
Phone: +1 (415) 513-1284
Email: patti.bank@westwicke.com
Frequently Asked Questions
What date will Ascendis Pharma report its Q2 2024 results?
Ascendis Pharma will report its second quarter 2024 financial results on September 3, 2024, after the markets close.
How can I access the conference call?
The conference call will be accessible through specific links provided by the company, allowing participants to engage in the discussion about the financial results.
What technology does Ascendis Pharma utilize?
The company employs its innovative TransCon technology platform to develop advanced therapies focusing on better patient outcomes.
Who can I contact for investor relations?
The investor relations contact is Tim Lee, who can be reached at +1 (650) 374-6343 or via email at tle@ascendispharma.com.
What are Ascendis Pharma's core values?
Ascendis Pharma's core values are Patients, Science, and Passion, reflecting its commitment to patient-centered research and innovation.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Related Articles
- Middlefield Canadian Income PCC Announces Latest NAV Details
- SoFi Technologies: Disruption in Financial Services
- Understanding Retirement Strategies to Ensure Financial Security
- FFW Corporation Declares $0.30 Quarterly Dividend
- Blink Charging Announces Leadership Transition
- Abercrombie & Fitch Achieves Strong Quarterly Sales Growth
- AGAPE ATP Corporation Announces Reverse Stock Split
- Chewy Inc. Reports Strong Q2 Earnings Results
- Alda Credit Fund II Announces Interim Financial Results
- Immix Biopharma Expands NEXICART-2 Trial with New Sites